|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA |
|
CHEBI:65132 |
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA |
|
An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid. It is a member of n-3 PUFA and a product of α-linolenoic acid metabolism. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Phani Vijay Garapati
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C43H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-34(52)71-27-26-45-33(51)24-25-46-41(55)38(54)43(2,3)29-64-70(61,62)67-69(59,60)63-28-32-37(66-68(56,57)58)36(53)42(65-32)50-31-49-35-39(44)47-30-48-40(35)50/h5-6,8-9,11-12,14-15,17-18,20-21,30-32,36-38,42,53-54H,4,7,10,13,16,19,22-29H2,1-3H3,(H,45,51)(H,46,55)(H,59,60)(H,61,62)(H2,44,47,48)(H2,56,57,58)/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-/t32-,36-,37-,38+,42-/m1/s1 |
MENFZXMQSYYVRK-CRCGJGBYSA-N |
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)n1cnc2c(N)ncnc12 |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
acyl donor
Any donor that can transfer acyl groups between molecular entities.
(via acyl-CoA )
|
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
has role
mouse metabolite
(CHEBI:75771)
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
is a
long-chain fatty acyl-CoA
(CHEBI:33184)
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
is a
unsaturated fatty acyl-CoA
(CHEBI:51006)
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
is conjugate acid of
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA(4−)
(CHEBI:74298)
|
|
Incoming
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA(4−)
(CHEBI:74298)
is conjugate base of
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
(CHEBI:65132)
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]sulfanyl}ethyl)amino]-3-hydroxy-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-CoA
|
ChEBI
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-coenzyme A
|
ChEBI
|
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-coenzyme A
|
ChEBI
|
4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl-CoA
|
ChEBI
|
4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl-coenzyme A
|
ChEBI
|
CoA(22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
LIPID MAPS
|
DHA-CoA
|
SUBMITTER
|
10574660
|
PubMed citation
|
Europe PMC
|
12897190
|
PubMed citation
|
Europe PMC
|
1971706
|
PubMed citation
|
Europe PMC
|
20026368
|
PubMed citation
|
Europe PMC
|
21184843
|
PubMed citation
|
Europe PMC
|
7836869
|
PubMed citation
|
Europe PMC
|
9548590
|
PubMed citation
|
Europe PMC
|
|